Stay informed with the latest litigation news. Explore now

IP Verse

Juno Therapeutics competitive analysis

Latest publications and patents of Juno Therapeutics New

Explore the latest publications and patents granted to Juno Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Sep 2, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Juno Therapeutics

EP3615653
Jul 23, 2025Oligomeric Particle Reagents And Methods Of Use ThereofGranted And Under Opposition
EP3664835
Oct 23, 2024Methods And Compositions For Preparing Genetically Engineered CellsGranted And Under Opposition
EP4219687
Aug 14, 2024Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive TherapyGranted And Under Opposition
EP3585402
Mar 6, 2024Compositions, Articles Of Manufacture And Methods Related To Dosing In Cell TherapyGranted And Under Opposition
EP3548084
Aug 23, 2023Methods For Determining Car-T Cells DosingRevoked

Latest patents of Juno Therapeutics opposed by its competitors

Explore Juno Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3664835
Oct 23, 2024Methods And Compositions For Preparing Genetically Engineered Cells1
EP4219687
Aug 14, 2024Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive Therapy1
EP3585402
Mar 6, 2024Compositions, Articles Of Manufacture And Methods Related To Dosing In Cell Therapy1
EP3548084
Aug 23, 2023Methods For Determining Car-T Cells Dosing1

Latest PTAB cases involving Juno Therapeutics New

Discover the latest PTAB cases involving Juno Therapeutics, highlighting their recent legal challenges and patent disputes.

Top competitors of Juno Therapeutics

Top competitors of Juno Therapeutics based on patent oppositions.